Express (EXPR), JPMorgan (JPM), Linn Energy (LINE), Onyx Pharmaceuticals (ONXX), Questcor (QCOR), Regal-Beloit (RBC), Regeneron Pharmaceuticals (REGN) and SandRidge Permanian Trust (PER) getting new coverage from analysts.
Raymond James (NYSE:RJF) initiated coverage on Express (EXPR). They have an "Outperform" rating on the company.
Evercore Partners initiated coverage on JPMorgan (JPM). They have an "Overweight" rating on the company.
Credit Suisse (NYSE:CS) initiated coverage on Linn Energy (LINE). They have a "Neutral" rating on the company.
Jefferies (NYSE:JEF) initiated coverage on Onyx Pharmaceuticals (ONXX). They hae a "Buy" rating and a price target of $44 on the company.
Jefferies initiated coverage on Questcor (QCOR). They have a "Buy" rating and a price target of $36 on the company.
William Blair initiated coverage on Regal-Beloit (RBC). They have a "Market Perform" rating on the company.
Jefferies initiated coverage on Regeneron Pharmaceuticals (REGN). They have a "Hold" rating and a price target of $66 on the company.
Oppenheimer initiated coverage on SandRidge Permanian Trust (PER). They have an "Outperform" rating and a price target of $24 on the company.
No comments:
Post a Comment